UPDATE 1-Neuralstem gets FDA OK to test stem cell drug in humans

September 21, 2009

Neuralstem Inc (CUR.A) said U.S. health regulators allowed the stem-cell research company to start an early-stage human trial of its spinal cord stem cells in Lou Gehrig’s disease, a fatal neuromuscular condition. (Reuters)